Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: A north central cancer treatment group trial

Winston W. Tan, Jacob B. Allred, Muhammad Salim, Patrick Flynn, Paul A.S. Fishkin, Philip J. Stella, Martin Wiesenfeld, Albert M. Bernath, Tom R. Fitch, Edith A. Perez

Research output: Contribution to journal › Article › peer-review

7 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II interventional study (N0337) of capecitabine in combination with vinorelbine and trastuzumab for first- or second-line treatment of HER2-positive metastatic breast cancer: A north central cancer treatment group trial'. Together they form a unique fingerprint.

Medicine & Life Sciences